SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
February 10, 2000
------------------------------------------------------
(Date of earliest event reported)
ESC MEDICAL SYSTEMS LTD.
------------------------------------------------------
(Exact Name of Registrant as Specified in its charter)
Israel 0-27572 N/A
(State or Jurisdiction (Commission File No.) (IRS Employer
of Incorporation Identification No.)
P.O. Box 240, Yokneam 20692, Israel
-------------------------------------------------------------
(Address of principal executive offices, including zip code)
011-972-4-959-9000
-------------------------------------------------------------
(Registrant's Telephone number, including area code)
No Applicable
-------------------------------------------------------------
(Former name or former address, if changed since last report)
Item 4. Change in Registrant's Certifying Accountants.
On February 10, 2000, the client/auditor relationship between ESC Medical
Systems Ltd. (the "Company") and Luboshitz, Kasierer & Co. ("LKC"), the
Company's independent accountants, ceased. During the years ended December
31, 1999 and 1998, and the subsequent interim period through February 10,
2000 (the date LKC ceased to be the Company's independent accountants), (i)
there were no disagreements with LKC on any matters of accounting
principles or practices, financial statement disclosure, or auditing scope
or procedure, which disagreements, if not resolved to the satisfaction of
LKC, would have caused LKC to make a reference to the subject matter of the
disagreements in connection with its reports in the financial statements
for such years and (ii) there were no "reportable events" as described in
Items 304(a)(1)(iv) of Regulations S-K. The independent accountant's
report of LKC on the Company's consolidated financial statements for the
years ended December 31, 1999 and 1998 contained no adverse opinion or
disclaimer of opinion and were not qualified or modified as to uncertainty,
audit scope or accounting principles.
The registrant has requested that LKC furnish it with a letter addressed to
the Securities and Exchange Commission stating whether or not it agrees
with the above statements. A copy of such letter dated February 10, 2000
is filed as Exhibit 16 this Form 8-K.
On January 17, 2000, the Company has decided to appoint, with the approval
of the Company's Board of Directors, the firm of Brightman, Almagor & Co,
member firm of Deloitte, Touche, Tohmatsu as its independent accountants
replacing LKC.
Item 7. Financial Statements and Exhibits
(a) Exhibits.
Exhibit 16 Letter of Luboshitz, Kasierer & Co.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
ESC MEDICAL SYSTEMS LTD.
By: /s/ Yacha Sutton
________________________________
Name: Yacha Sutton
Title: Chief Executive Officer
Dated: February 14, 2000
Haifa, February 10, 2000
Office of the Chief Accountant
Securities and Exchange Commission
450 Fifth Street, N.W.
Washington, D.C. 20549
Dear Sir/Madam:
We have read paragraphs I, II of item 4 included in the Form 8-K dated
February 10, 2000 of ESC Medical Systems Ltd. to be filed with the
Securities and Exchange Commission and are in agreement with the statements
contained therein.
Very truly yours,
/s/ Luboshitz Kasierer
------------------------------
Luboshitz Kasierer
Member Firm of Arthur Andersen
cc: Mr. Yacha Sutton C.E.O. ESC Medical Systems Ltd.
